Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$209.36 USD
-1.69 (-0.80%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $209.32 -0.04 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$209.36 USD
-1.69 (-0.80%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $209.32 -0.04 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
Zacks News
What Makes Inspire (INSP) a New Buy Stock
by Zacks Equity Research
Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights Inspire Medical Systems, Olink Holding and Health Catalyst
by Zacks Equity Research
Inspire Medical Systems, Olink Holding and Health Catalyst have been highlighted in this Industry Outlook article.
3 Medical Info Systems Stocks Countering Industry-wide Headwinds
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWM
Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWO
Best Momentum Stocks to Buy for February 21st
by Zacks Equity Research
INSP and BZLFY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 21, 2023.
New Strong Buy Stocks for February 21st
by Zacks Equity Research
EMBC, INSP, REPYY, BZLFY and CVI have been added to the Zacks Rank #1 (Strong Buy) List on February 21, 2023.
Best Momentum Stocks to Buy for February 17th
by Zacks Equity Research
INSP, ABNB and HLF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 17, 2023.
New Strong Buy Stocks for February 17th
by Zacks Equity Research
KNBWY, INSP, HLF, VTNR and HBT have been added to the Zacks Rank #1 (Strong Buy) List on February 17, 2023.
Best Momentum Stocks to Buy for February 14th
by Zacks Equity Research
INSP and RL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 14, 2023.
New Strong Buy Stocks for February 14th
by Zacks Equity Research
INSP, ALK, SSKN, NVO and TBPH have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2023.
Molina Healthcare (MOH) Q4 Earnings Beat on Solid Medicaid Unit
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results benefit from its strong Medicaid and Medicare businesses. Management expects 2023 adjusted EPS at a minimum of $19.75.
Inspire Medical (INSP) Q4 Earnings, Revenues Top Estimates
by Zacks Equity Research
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the fourth quarter.
Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 118.52% and 0.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWM
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 20% and 14.19%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Inspire (INSP) Soars 7.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
3 Medical Info System Stocks to Gain on Rising Demand for Digital Health
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Inc. (INSP), Axonics (AXNX), and Pulmonx Corporation (LUNG) are expected to gain on rising demand for telehealth.
Wall Street Analysts Believe Inspire (INSP) Could Rally 46%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 46.4% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
CareCloud, Inc. (MTBC) Surges 11%: Is This an Indication of Further Gains?
by Zacks Equity Research
CareCloud, Inc. (MTBC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Inspire (INSP) Stock Jumps 5.6%: Will It Continue to Soar?
by Zacks Equity Research
Inspire (INSP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 10.17% and 15.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 21.79% and 6.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Inspire Medical Systems (INSP) Q1 Earnings Expected to Decline
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.